Survival | Division | Test set | Validation set | ||||
---|---|---|---|---|---|---|---|
 |  | n | Median RFS, years (95% CI) | 10-year RFS, percentage (SEM) | n | Median RFS, years (95% CI) | 10 year RFS, percentage (SEM) |
RFS | Overall cohort | 313 | 5.2 (3.9–6.5) | 38.3 (2.9) | 289 | 5.8 (4.4–7.3) | 38.1 (2.9) |
 | 0 | 38/227 | NR | 75.4 (7.1) | 40/219 | 9.7 (5.5–14.0) | 47.8 (8.4) |
 | 1–4 | 154/227 | 4.8 (3.6–6.1) | 35.3 (4.1) | 146/219 | 5.8 (3.9–7.7) | 37.8 (4.2) |
 | 5–8 | 35/227 | 1.6 (0.8–2.3) | 19.3 (7.0) | 33/219 | 2.4 (0.9–3.8) | 30.3 (8.0) |
 | All markers | 227/227 | 5.2 (3.6–6.9) | 39.8 (3.4) | 219/219 | 5.8 (4.2–7.5) | 38.5 (3.4) |
OS | Overall cohort | 313 | 6.7 (5.7–7.8) | 39.5 (3.4) | 289 | 7.3 (5.9–8.6) | 39.1 (2.9) |
 | 0 | 38/227 | 15.5 (10.9–20.1) | 67.6 (7.7) | 40/219 | 9.3 (5.5–13.1) | 47.5 (7.9) |
 | 1–4 | 154/227 | 6.4 (5.3–7.5) | 35.1 (3.8) | 146/219 | 7.8 (5.8–9.9) | 38.4 (4.0) |
 | 5–8 | 35/227 | 2.7 (1.1–4.3) | 21.6 (6.8) | 33/219 | 3.3 (1.7–4.9) | 30.3 (8.0) |
 | All markers | 227/227 | 6.6 (5.2–8.0) | 38.2 (3.2) | 219/219 | 7.6 (6.0–9.1) | 38.8 (3.3) |